Back to News
Market Impact: 0.38

BofA reiterates AST SpaceMobile stock Neutral after satellite setback

ASTSUBSDBAMZNGSAT
Analyst InsightsCompany FundamentalsCorporate Guidance & OutlookInfrastructure & DefenseTechnology & InnovationInvestor Sentiment & Positioning

BofA reiterated a Neutral rating and $100 price target on AST SpaceMobile after the company failed to place Bluebird 7 into its planned orbit, adding pressure to a stock already down 13.6% over the past week to $78.95. The setback raises risk to the company’s revised goal of about 45 satellites in orbit by end-2026, with BofA estimating a shortfall of roughly seven satellites assuming 5.5 satellites per launch. While the failure is viewed as a negative shock, BofA said it does not fundamentally alter the business model.

Analysis

The market is treating this as a one-shot operational miss, but the more important effect is that it raises the variance around ASTS’s entire commercialization schedule. For a pre-scale network business, one failed deployment is less about the lost hardware and more about the compounding delay to coverage density, revenue recognition, and investor confidence in future launch cadence; that’s why the stock can de-rate faster than the intrinsic value of the satellite itself. Insurance may mute the P&L impact, but it does nothing for the sequencing risk embedded in the next 6-12 months of launches. The second-order winner is not necessarily the most obvious competitor; it is any direct-to-device alternative with nearer-term deployment optionality and less execution beta. If ASTS is forced into smaller stacked launches or longer gaps between launches, the market will likely reassign probability to incumbents and adjacent names with easier paths to initial service, while suppliers and launch providers with diversified manifests become relatively more valuable than single-customer dependencies. This also matters for ASTS’s capital needs: any slippage in satellite count can force the company to spend more on launch logistics per delivered unit, compressing the path to economics even if the technical thesis remains intact. The catalyst map is asymmetric. In the next few weeks, the stock will likely trade on launch updates and whether management can prove the next batch is genuinely de-risked; over the next few months, the key question is whether cadence can recover enough to keep 2026 coverage targets credible. If the company strings together 2-3 clean launches, the current drawdown can reverse quickly because the debate is about execution, not demand; if another anomaly occurs, the de-rating could extend materially as the market prices in schedule slippage and lower terminal share. Contrarian view: the selloff may be partially overdone if investors are extrapolating a single failure into a structural inability to scale. For a network buildout, the value is highly convex to the first few successful multi-satellite launches, so the stock could snap back sharply on a clean mission sequence. The right lens is not whether one satellite was lost, but whether the company can restore launch cadence before the market concludes that the 2026 target is aspirational rather than executable.